SU697049A3 - Способ получени меркаптоациламинокислот или их солей - Google Patents
Способ получени меркаптоациламинокислот или их солейInfo
- Publication number
- SU697049A3 SU697049A3 SU782632600A SU2632600A SU697049A3 SU 697049 A3 SU697049 A3 SU 697049A3 SU 782632600 A SU782632600 A SU 782632600A SU 2632600 A SU2632600 A SU 2632600A SU 697049 A3 SU697049 A3 SU 697049A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- mercaptopropanoyl
- mercapto
- ethyl acetate
- concentrated
- arginine
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims 5
- 239000002253 acid Substances 0.000 title claims 4
- 150000003839 salts Chemical class 0.000 title claims 4
- 150000007513 acids Chemical class 0.000 title 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 18
- -1 3-mercaptopropanoyl Chemical group 0.000 claims 16
- 125000000217 alkyl group Chemical group 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 229960004799 tryptophan Drugs 0.000 claims 4
- 229960004441 tyrosine Drugs 0.000 claims 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 3
- 229960003767 alanine Drugs 0.000 claims 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims 3
- 239000000047 product Substances 0.000 claims 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims 2
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims 2
- 235000011114 ammonium hydroxide Nutrition 0.000 claims 2
- 229910052796 boron Inorganic materials 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- JIAFOCJABIEPNM-BYPYZUCNSA-N (2s)-2-(3-sulfanylpropanoylamino)propanoic acid Chemical compound OC(=O)[C@H](C)NC(=O)CCS JIAFOCJABIEPNM-BYPYZUCNSA-N 0.000 claims 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 claims 1
- BDFAOUQQXJIZDG-UHFFFAOYSA-N 2-methylpropane-1-thiol Chemical compound CC(C)CS BDFAOUQQXJIZDG-UHFFFAOYSA-N 0.000 claims 1
- JTNCEQNHURODLX-UHFFFAOYSA-N 2-phenylethanimidamide Chemical compound NC(=N)CC1=CC=CC=C1 JTNCEQNHURODLX-UHFFFAOYSA-N 0.000 claims 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims 1
- 239000004475 Arginine Substances 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims 1
- 241000288673 Chiroptera Species 0.000 claims 1
- 229920002307 Dextran Polymers 0.000 claims 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical class C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 claims 1
- 229930064664 L-arginine Natural products 0.000 claims 1
- 235000014852 L-arginine Nutrition 0.000 claims 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 1
- 108010077895 Sarcosine Proteins 0.000 claims 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 1
- 229910021529 ammonia Inorganic materials 0.000 claims 1
- 239000000908 ammonium hydroxide Substances 0.000 claims 1
- 238000005915 ammonolysis reaction Methods 0.000 claims 1
- 239000003957 anion exchange resin Substances 0.000 claims 1
- 239000008346 aqueous phase Substances 0.000 claims 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 1
- 239000000872 buffer Substances 0.000 claims 1
- 239000007853 buffer solution Substances 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000007795 chemical reaction product Substances 0.000 claims 1
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 claims 1
- 238000000354 decomposition reaction Methods 0.000 claims 1
- 239000002024 ethyl acetate extract Substances 0.000 claims 1
- 239000000706 filtrate Substances 0.000 claims 1
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims 1
- 125000001041 indolyl group Chemical group 0.000 claims 1
- 239000003456 ion exchange resin Substances 0.000 claims 1
- 229920003303 ion-exchange polymer Polymers 0.000 claims 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims 1
- 235000019341 magnesium sulphate Nutrition 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000012074 organic phase Substances 0.000 claims 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 1
- 229960005190 phenylalanine Drugs 0.000 claims 1
- 235000008729 phenylalanine Nutrition 0.000 claims 1
- 229910000343 potassium bisulfate Inorganic materials 0.000 claims 1
- 125000001325 propanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 claims 1
- GAPYKZAARZMMGP-UHFFFAOYSA-N pyridin-1-ium;acetate Chemical compound CC(O)=O.C1=CC=NC=C1 GAPYKZAARZMMGP-UHFFFAOYSA-N 0.000 claims 1
- 239000011541 reaction mixture Substances 0.000 claims 1
- 239000011347 resin Substances 0.000 claims 1
- 229920005989 resin Polymers 0.000 claims 1
- 229940043230 sarcosine Drugs 0.000 claims 1
- 239000000741 silica gel Substances 0.000 claims 1
- 229910002027 silica gel Inorganic materials 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 238000000638 solvent extraction Methods 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 1
- 229960004295 valine Drugs 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
Claims (1)
1 . N-- ( Пример lo N--{ 3 меркаптопропаноил )Ь-аланин. N-- { 3-бенэоилтиопропаноил) -Ь-ала-нин (4,2 г) раствор ют .в скеси во.цы {7,5 мл) и концентрированной гидрэокиси амглони (б мл),, Спуст 1 ч смесь разбавл ют водой,, отфильт-ровьт вагот и фильтрат экстрагируют зтилацвтатом„ Водную фазу подкисл ют концентрировв,нкой сол ной кислотой и экстрагируют этилацетатом. Органическую фазу промывают водой, высушивают и концентрируют досуха в вакууме. Остаток кристаллизуют из смеси этилацетата с гексаном и получают 1,87 г N-(З-меркаптопропа-ноил )-L-аланина, т,пл. /9-8l C.. Пример 2„ N-( 3 маркаптопропаноил )-Ь-лейцин, Замен,т (3 бензоил.тиопропако,1л L-аланим в ,примере 1 N-(3-бен-зо-илтиопропаноил ) -N-лeйLT,инoм (5,46 г) получают 2,75 г N--(З-меркаптопропаноил )ь-лейцина, т„пл, 131-132« Это вещество перекристаллизовывают из ацетонитрила. Пример 3 N-(3-меркаптопроп ноил)-L-шенилапанин К- ( 3-бекзоилтиопропаноил) -1,-фени аланин (1,78 г) раствор ют в смеси ды (20 МП) и 1нФгидроокиси натри (5,5мл)Л этому раствору добавл ютконцентрированную гидроокись аммони ( 20мл) F затем зоду (20мл)„Через 3ч реакционную смесь экстрагируют этил ной сол ной кислотой и повторно экстрагируют этиладетатоМв Второй экстракт этилацетата промыварэт водой, сушат над сульфатом магни и коицен трирутат в вакуума досуха- Остаток хроматографиру от на колонке с силикагелем смесью бензола с уксусной кислотой и получают О,-47 г N-(3-меркаптопропаноил ) -т,фенила.ланика Т.пЛб 10б 107°С П р и м е р 4 , пропаноил) -1.-аргинин N (З-бензоилтиопропаноил)-L-аргиник (1 г) раствор ют при энергичном перемешивании в смеси вохи {5 мл) и концентрированного растЕ;о ра аммиака (5 мл) о Через 1 ч расл Бор экстрагируют этилсщетатом и концентрируют досуха в накууме Ос таток хроматографируют на колонке: с DEAE Sephudex (анионообменна смола на основе декстрана) (85 IVLT:) буферньи4 0,005 М раствором бикар&о ната гч--аЛопк , Фракции,, содержащие К -(3-меркаптопропаноил)-L-аргинин объедин ют и лиофилиэ;лот. чтобы уд лить бикарбонат а 4монк г получает 200 ,пл 230°С {начало разло -:е ни при 200С) S Пример 5, N--(З-меркаптопр паноил)саркозин Замен N- (3 бенэоилткопропанс ил )L-аланин в методике примера 12 N-(З-бензоилтиопропаноил)-саркозкном (2,8 г), получают 1,65 г сырого и-(3-меркаптопропаноил)-саркоЭина. Это вещество перевод т в соль дициклогексиламмони (2,7 г), т. пл. J,57- 158 С, и очищенную соль перевод т в свободную кислоту путем распределени между этилацетатом и 10%-ным бисульфатом кали . При м е р б, N(3-меркаптопропаноил ) -N-триптофан1 Замен L-аланин на N-триптофан и обрабатыва затем продукт реакции по методике примера 2, получают N-- (З-бензоилтиопропаноил)-L-триптофан и N(3-меркаптопропаноил)-L-триптофан Пример 7. (3-мepкaптo-2-мe тилпpoпaнoил ) -L-аргинин (З-ацетилтио-2-метилпропаноил) -L-аргинин (1 г) раствор ют в смеси воды (5 мл) и концентрированного раствора аммиака (5 мл) -. Через 1 ч при омнатной температуре раствор концентрируют в вакууме до 3 мл (не нагревать) и ,добавл ют ионообменную смолу AC-50W до величины рН приблизительно 4, Суспензию загружают в колонку с той же смолой, и N(3 меркапто-2-метилпропаноил )-Ь-аргИнин элюируют буферным раствором пиридив-ацетата , рН 6,5. Расгворитель удал ют в вакууме и остаток сушат при температуре ниже 0°С, выход 0,86 г, т„пл. 100°С, Пример 8. N-(З-мерка.пто-2-метилпропанрил )-L-тирозин. Замен Ь-валин на L-тирозин, и обрабатыва затем продукт по методике примера 2, получают Ы-(3-ацетилтио 2-метилпропаноил )Ь тирозин и N-(З-меркапто-2-мегилпропаноил)-L-тирозин Пример 9, N-(3-мepкaптo 2-мeтилпpoпaнoил ).-L-тpиптoфaн , Замен L зaлин на L тpиптoфaн, и обрабатыва затем продукт реакции по методике примера 2 получают N-(3 aцeтилтиo 2 мeтил:apoпaнoил-L-тpиптoфан и N-(3-мepкaптo-2-мeтилпpoпaнoил ) -L-триптофан, Пример 10, (3-меркапто-2-бензилпропаноил ) -L aprHHHH. Замен N -(3-aцeтилтиo-2-мeтилпpoпaнoил )-L-apгинин в методике примера 7 на N -(3-aцeтилтиo-2-бeнзилпpoпaнoил ) -L-аргинин , получают (З-меркапто-2-беншлпропаноил)-L-аргинин . Формула изобретени Способ получени меркаптоацилаш-1нокислот общей Н-$- tHrCH-CC-W-tHyCO ОН , где R - алкил , или алкил, замещенный фенилом, гуанидино-, индолил-группой или оксифенйльной группой; R 2 водород, НИЗШИЙ алкил Кз - алкил или алкил, заме щенный фенилом, или их солей, отличаюади с тем, что соединени формулы II I R4CO-S-CH2-tH-CO-N-№-COOH, где R , R2/ R-, имеют указанные зна9° чени , а R -адТкил или фенил, подвергают аммонолизу и целевой продукт выдел ют в виде свободного соединени или соли. Источники информации, прин тые во внимание при экспертизе 1. Патент США № 3897480, кл. 260-470, опублик. 29.17.75.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/684,606 US4053651A (en) | 1976-05-10 | 1976-05-10 | Compounds and method for alleviating angiotensin related hypertension |
Publications (1)
Publication Number | Publication Date |
---|---|
SU697049A3 true SU697049A3 (ru) | 1979-11-05 |
Family
ID=24748765
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU772478851A SU818479A3 (ru) | 1976-05-10 | 1977-05-10 | Способ получени меркаптоацилами-НОКиСлОТ |
SU782632596A SU955857A3 (ru) | 1976-05-10 | 1978-07-05 | Способ получени меркаптоациламинокислот или их солей |
SU782632600A SU697049A3 (ru) | 1976-05-10 | 1978-07-05 | Способ получени меркаптоациламинокислот или их солей |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU772478851A SU818479A3 (ru) | 1976-05-10 | 1977-05-10 | Способ получени меркаптоацилами-НОКиСлОТ |
SU782632596A SU955857A3 (ru) | 1976-05-10 | 1978-07-05 | Способ получени меркаптоациламинокислот или их солей |
Country Status (21)
Country | Link |
---|---|
US (2) | US4053651A (ru) |
JP (1) | JPS52136117A (ru) |
AU (1) | AU513622B2 (ru) |
BE (1) | BE854458A (ru) |
CA (1) | CA1119177A (ru) |
CH (2) | CH620202A5 (ru) |
CS (1) | CS204001B2 (ru) |
DD (1) | DD130477A5 (ru) |
DE (1) | DE2717548A1 (ru) |
DK (1) | DK203177A (ru) |
FR (2) | FR2372624A1 (ru) |
GB (1) | GB1577415A (ru) |
HU (1) | HU177750B (ru) |
IE (1) | IE44821B1 (ru) |
NL (1) | NL7704712A (ru) |
NO (1) | NO771623L (ru) |
PL (2) | PL107991B1 (ru) |
SE (1) | SE7705382L (ru) |
SU (3) | SU818479A3 (ru) |
YU (1) | YU116877A (ru) |
ZA (1) | ZA772256B (ru) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2572830C2 (ru) * | 2010-03-17 | 2016-01-20 | Акцо Нобель Кемикалз Интернэшнл Б.В. | Способ деполимеризации полисульфидов и получения простых бисмеркаптодиэфиров |
Families Citing this family (113)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS535112A (en) * | 1976-03-08 | 1978-01-18 | Santen Pharmaceutical Co Ltd | New cysteine derivatives |
US4140797A (en) * | 1976-05-10 | 1979-02-20 | E. R. Squibb & Sons, Inc. | Method for alleviating angiotensin related hypertension |
US4339600A (en) * | 1976-05-10 | 1982-07-13 | E. R. Squibb & Sons, Inc. | Compounds for alleviating angiotensin related hypertension |
US4178291A (en) * | 1976-12-03 | 1979-12-11 | E. R. Squibb & Sons, Inc. | Substituted acyl derivatives of amino acids |
US4176235A (en) * | 1976-12-03 | 1979-11-27 | E. R. Squibb & Sons, Inc. | Substituted acyl derivatives of amino acids |
US4206121A (en) * | 1976-12-03 | 1980-06-03 | E. R. Squibb & Sons, Inc. | Substituted acyl derivatives of amino acids |
US4175199A (en) * | 1976-12-03 | 1979-11-20 | E. R. Squibb & Sons, Inc. | Substituted acyl derivatives of amino acids |
US4116962A (en) * | 1976-12-03 | 1978-09-26 | E. R. Squibb & Sons, Inc. | Pyrrolidine and piperidine-2-carboxylic acid derivatives |
US4091024A (en) * | 1976-12-03 | 1978-05-23 | E. R. Squibb & Sons, Inc. | Pyrrolidine and piperidine-2-carboxylic acid derivatives |
US4113715A (en) * | 1977-01-17 | 1978-09-12 | E. R. Squibb & Sons, Inc. | Amino acid derivatives |
US4611002A (en) * | 1977-07-14 | 1986-09-09 | E. R. Squibb And Sons, Inc. | Carboxymethyl esters of mercaptopropanoic acids as enkephalinase inhibitors |
US4206137A (en) * | 1978-03-27 | 1980-06-03 | E. R. Squibb & Sons, Inc. | Thioalkanoylalkanoic acid compounds |
US4927853A (en) * | 1978-04-24 | 1990-05-22 | Massachusetts Institute Of Technology | Composition for increasing blood pressure |
US4690937A (en) * | 1979-08-14 | 1987-09-01 | University Of Miami | Anti-hypertensive agents |
GR73585B (ru) * | 1978-09-11 | 1984-03-26 | Univ Miami | |
US4690939A (en) * | 1979-08-14 | 1987-09-01 | University Of Miami | Anti-hypertensive agents |
US4690938A (en) * | 1979-08-14 | 1987-09-01 | University Of Miami | Anti-hypertensive agents |
US4698356A (en) * | 1979-08-14 | 1987-10-06 | University Of Miami | Anti-hypertensive agents |
US4690940A (en) * | 1979-08-14 | 1987-09-01 | University Of Miami | Anti-hypertensive agents |
US4698355A (en) * | 1979-08-14 | 1987-10-06 | University Of Miami | Anti-hypertensive agents |
US4695577A (en) * | 1979-08-14 | 1987-09-22 | University Of Miami | Anti-hypertensive agents |
ZA794723B (en) * | 1978-09-11 | 1980-08-27 | Univ Miami | Anti-hypertensive agents |
JPS6011888B2 (ja) * | 1978-10-11 | 1985-03-28 | 参天製薬株式会社 | リウマチ疾患治療薬 |
JPS6058908B2 (ja) * | 1978-10-11 | 1985-12-23 | 参天製薬株式会社 | システイン誘導体 |
US4211786A (en) * | 1979-03-08 | 1980-07-08 | E. R. Squibb & Sons, Inc. | Mercaptoacyldihydropyrazole carboxylic acid derivatives |
US4235885A (en) * | 1979-06-25 | 1980-11-25 | E. R. Squibb & Sons, Inc. | Inhibitors of mammalian collagenase |
US4256761A (en) * | 1979-07-13 | 1981-03-17 | Usv Pharmaceutical Corporation | Antihypertensive amides |
US4565825A (en) * | 1979-07-13 | 1986-01-21 | Usv Pharmaceutical Corp. | Antihypertensive N-benzimidazolyl- and N-imidazolyl-amino acid derivatives |
US4549992A (en) * | 1979-07-13 | 1985-10-29 | Usv Pharmaceutical Corp. | Antihypertensive amides |
DE2951353A1 (de) * | 1979-12-20 | 1981-07-02 | Basf Ag, 6700 Ludwigshafen | Kationische farbstoffe |
PT70158A1 (en) * | 1980-03-03 | 1982-03-01 | Univ Miami | Process for preparing anti-hypertensive agents |
US4692458A (en) * | 1980-03-05 | 1987-09-08 | University Of Miami | Anti-hypertensive agents |
US4690936A (en) * | 1980-03-05 | 1987-09-01 | University Of Miami | Anti-hypertensive agents |
US4734420A (en) * | 1980-03-05 | 1988-03-29 | University Of Miami | Anti-hypertensive agents |
US4482725A (en) * | 1980-04-03 | 1984-11-13 | E. R. Squibb & Sons, Inc. | S-Acylation products of mercaptoacyl amino acids and carboxyl group containing diuretics |
FR2480747A1 (fr) * | 1980-04-17 | 1981-10-23 | Roques Bernard | Derives d'acides amines et leur application therapeutique |
ZA811340B (en) * | 1980-06-09 | 1982-03-31 | Morton Norwich Products Inc | N-(cycloalkyl)amino acid compounds |
AU543804B2 (en) * | 1980-10-31 | 1985-05-02 | Takeda Chemical Industries Ltd. | Amides having bicyclic substituents on nitrogen |
US4521607A (en) * | 1981-02-27 | 1985-06-04 | Takeda Chemical Industries, Ltd. | Chromanyl glycines |
JPS57142962A (en) * | 1981-02-28 | 1982-09-03 | Santen Pharmaceut Co Ltd | Cyclodextrin clathrate compound of sulfur-containing compound |
US4329495A (en) * | 1981-05-18 | 1982-05-11 | Pfizer Inc. | Enkephalinase enzyme inhibiting compounds |
US4432971A (en) * | 1981-08-03 | 1984-02-21 | E. R. Squibb & Sons, Inc. | Phosphonamidate compounds |
US4432972A (en) * | 1981-08-03 | 1984-02-21 | E. R. Squibb & Sons, Inc. | Phosphonamidate compounds |
US4401677A (en) * | 1981-10-09 | 1983-08-30 | E. R. Squibb & Sons, Inc. | Enkephalinase inhibitors |
US4474795A (en) * | 1981-10-09 | 1984-10-02 | E. R. Squibb & Sons, Inc. | Enkephalinase inhibitors |
US4474799A (en) * | 1981-10-09 | 1984-10-02 | E. R. Squibb & Sons, Inc. | Enkephalinase inhibitors |
US4396772A (en) * | 1981-11-23 | 1983-08-02 | F. R. Squibb & Sons, Inc. | Phosphinylalkanoyl amino acids |
IT1140394B (it) * | 1981-12-23 | 1986-09-24 | Maggioni Farma | Dipeptidi contenenti un residuo di metionina ad attivita' epatoprotettrice |
US4555506A (en) * | 1981-12-24 | 1985-11-26 | E. R. Squibb & Sons, Inc. | Phosphorus containing compounds and use as hypotensives |
JPS58140065A (ja) * | 1982-02-10 | 1983-08-19 | Meito Sangyo Kk | メルカプトベンジル脂肪酸誘導体類及びその製法 |
US4452791A (en) * | 1982-03-15 | 1984-06-05 | E. R. Squibb & Sons, Inc. | Aminoalkyl and related substituted phosphinic acid angiotensin converting enzyme inhibitors |
US4560680A (en) * | 1982-03-15 | 1985-12-24 | E. R. Squibb & Sons, Inc. | Aminoalkyl and related substituted phosphinic acid angiotensin converting enzyme inhibitors |
US4703043A (en) * | 1982-06-23 | 1987-10-27 | E. R. Squibb & Sons, Inc. | Phosphonyl hydroxyacyl amino acid derivatives as antihypertensive |
US4616005A (en) * | 1982-06-23 | 1986-10-07 | E. R. Squibb & Sons, Inc. | Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives |
US4452790A (en) * | 1982-06-23 | 1984-06-05 | E. R. Squibb & Sons, Inc. | Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives |
US4470973A (en) * | 1982-07-19 | 1984-09-11 | E. R. Squibb & Sons, Inc. | Substituted peptide compounds |
US4736066A (en) * | 1982-07-19 | 1988-04-05 | E. R. Squibb & Sons, Inc. | Intermediate for substituted peptide compounds |
US4661515A (en) * | 1982-07-21 | 1987-04-28 | Usv Pharmaceutical Corporation | Compounds having angiotensin converting enzyme inhibitory activity and diuretic activity |
IL69228A0 (en) * | 1982-07-21 | 1983-11-30 | Usv Pharma Corp | Compounds having diuretic activity and angiotensin converting inhibitory activity,methods of the preparation thereof and pharmaceutical compositions containing the same |
US4621092A (en) * | 1982-07-22 | 1986-11-04 | E. R. Squibb & Sons, Inc. | Substituted proline compounds, composition and method of use |
US4742067A (en) * | 1982-07-22 | 1988-05-03 | E. R. Squibb & Sons, Inc. | Acylalkylaminocarbonyl substituted amino and imino acid compounds |
US4623729A (en) | 1982-07-22 | 1986-11-18 | E. R. Squibb & Sons, Inc. | Acylalkylaminocarbonyl substituted amino and imino acid compounds |
US4524212A (en) * | 1982-09-27 | 1985-06-18 | E. R. Squibb & Sons, Inc. | Acyloxyketone substituted imino and amino acids |
FR2540495B1 (fr) * | 1983-02-07 | 1986-02-14 | Roussel Uclaf | Nouveaux derives de o-mercaptopropanamide et de ses homologues, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus |
US4798904A (en) * | 1983-10-03 | 1989-01-17 | E. R. Squibb & Sons, Inc. | Certain [(lower alkanoyl-thio)methyl-1-oxo-3-phenyl propyl amino]benzene lower alkanoic acid or ester derivatives which inhibit enkephalinase |
US4722810A (en) * | 1984-08-16 | 1988-02-02 | E. R. Squibb & Sons, Inc. | Enkephalinase inhibitors |
US4774256A (en) * | 1983-10-03 | 1988-09-27 | E. R. Squibb & Sons, Inc. | Use of enkephalinase inhibitors as analgesic agents |
US4595700A (en) * | 1984-12-21 | 1986-06-17 | G. D. Searle & Co. | Thiol based collagenase inhibitors |
US4929641B1 (en) * | 1988-05-11 | 1994-08-30 | Schering Corp | Mercapto-acylamino acid antihypertensives |
EP0254032A3 (en) * | 1986-06-20 | 1990-09-05 | Schering Corporation | Neutral metalloendopeptidase inhibitors in the treatment of hypertension |
US4801609B1 (en) * | 1987-03-27 | 1993-11-09 | Mercapto-acylamino acid antihypertensives | |
US5262436A (en) * | 1987-03-27 | 1993-11-16 | Schering Corporation | Acylamino acid antihypertensives in the treatment of congestive heart failure |
CA1337400C (en) * | 1987-06-08 | 1995-10-24 | Norma G. Delaney | Inhibitors of neutral endopeptidase |
US5210266A (en) * | 1987-12-03 | 1993-05-11 | Dainippon Pharmaceutical Co., Ltd. | N-substituted mercaptopropanamide derivatives |
US5179125A (en) * | 1987-12-03 | 1993-01-12 | Dainippon Pharmaceutical Co., Ltd. | N-substituted mercaptopropanamide derivatives |
EP0318859A3 (en) * | 1987-12-03 | 1990-08-16 | Dainippon Pharmaceutical Co., Ltd. | N-substituted mercaptopropanamide derivatives |
US5292926A (en) * | 1988-01-25 | 1994-03-08 | Santen Pharmaceutical Co., Ltd. | Cysteine derivatives |
US5356890A (en) * | 1988-06-15 | 1994-10-18 | Brigham And Women's Hospital | S-nitroso derivatives of ace inhibitors and the use thereof |
US5002964A (en) * | 1988-06-15 | 1991-03-26 | Brigham & Women's Hospital | S-nitrosocaptopril compounds and the use thereof |
US5187183A (en) * | 1988-06-15 | 1993-02-16 | Brigham & Women's Hospital | S-nitroso derivatives of ACE inhibitors and the use thereof |
US5025001A (en) * | 1988-06-15 | 1991-06-18 | Brigham And Women's Hospital | S-nitroso derivatives of ACE inhibitors and the use thereof |
US4879309A (en) * | 1988-09-27 | 1989-11-07 | Schering Corporation | Mercapto-acylamino acids as antihypertensives |
ZA902661B (en) * | 1989-04-10 | 1991-01-30 | Schering Corp | Mercapto-acyl amino acids |
CA2021409A1 (en) * | 1989-08-21 | 1991-02-22 | Donald S. Karanewsky | Phosphonate substituted amino or imino acids useful as antihypertensives |
AU7168091A (en) * | 1989-12-22 | 1991-07-24 | Schering Corporation | Mercaptocycloacyl aminoacid endopeptidase inhibitors |
JPH06102648B2 (ja) * | 1990-05-17 | 1994-12-14 | シェリング・コーポレーション | メルカプトアシルアミノ酸のジスルフィド誘導体 |
FR2679564A1 (fr) * | 1991-07-23 | 1993-01-29 | Inst Nat Sante Rech Med | Nouveaux acylmercaptoalcanoldipeptides, leur preparation et les compositions qui les contiennent. |
US5504080A (en) * | 1992-10-28 | 1996-04-02 | Bristol-Myers Squibb Co. | Benzo-fused lactams |
US5424447A (en) * | 1993-07-07 | 1995-06-13 | The Medical College Of Wisconsin Research Foundation, Inc. | Heme binding compounds and use thereof |
FR2712286B1 (fr) * | 1993-11-12 | 1995-12-22 | Oreal | Nouveaux N-mercaptoalkyl alcanediamines et leur utilisation. |
DE4430023A1 (de) * | 1994-08-24 | 1996-02-29 | Boehringer Mannheim Gmbh | Elektrochemischer Sensor |
IT1273455B (it) * | 1995-01-27 | 1997-07-08 | Zambon Spa | Derivati tiolici ad attivita' inibitrice delle metallopeptidasi |
US5670545A (en) * | 1996-02-09 | 1997-09-23 | Board Of Regents Of The University Of Colorado | Method for the treatment of ischemic disease and reperfusion injury and the prevention of the adverse effects of reactive oxygen species |
FR2745571B1 (fr) * | 1996-03-04 | 1998-06-19 | Inst Nat Sante Rech Med | Nouveaux derives soufres comportant une liaison amide, leur procede de preparation, leur application a titre de medicaments, et les compositions pharmaceutiques les renfermant |
GB0221169D0 (en) * | 2002-09-12 | 2002-10-23 | Univ Bath | Crystal |
GB0600406D0 (en) | 2006-01-10 | 2006-02-15 | Univ Bath | Crystal |
US11229746B2 (en) | 2006-06-22 | 2022-01-25 | Excelsior Medical Corporation | Antiseptic cap |
US9259535B2 (en) | 2006-06-22 | 2016-02-16 | Excelsior Medical Corporation | Antiseptic cap equipped syringe |
US9078992B2 (en) | 2008-10-27 | 2015-07-14 | Pursuit Vascular, Inc. | Medical device for applying antimicrobial to proximal end of catheter |
US10166381B2 (en) | 2011-05-23 | 2019-01-01 | Excelsior Medical Corporation | Antiseptic cap |
EP2731658B1 (en) | 2011-07-12 | 2020-04-01 | Pursuit Vascular, Inc. | Device for delivery of antimicrobial agent into trans-dermal catheter |
WO2015168677A1 (en) | 2014-05-02 | 2015-11-05 | Excelsior Medical Corporation | Strip package for antiseptic cap |
PL224139B1 (pl) | 2014-08-01 | 2016-11-30 | Ekobenz Spółka Z Ograniczoną Odpowiedzialnością | Mieszanka paliwowa szczególnie do silników z zapłonem iskrowym |
AU2016262400B2 (en) | 2015-05-08 | 2021-01-21 | Icu Medical, Inc. | Medical connectors configured to receive emitters of therapeutic agents |
EP4194043A1 (en) | 2016-10-14 | 2023-06-14 | ICU Medical, Inc. | Sanitizing caps for medical connectors |
WO2018204206A2 (en) | 2017-05-01 | 2018-11-08 | Icu Medical, Inc. | Medical fluid connectors and methods for providing additives in medical fluid lines |
US11517732B2 (en) | 2018-11-07 | 2022-12-06 | Icu Medical, Inc. | Syringe with antimicrobial properties |
US11400195B2 (en) | 2018-11-07 | 2022-08-02 | Icu Medical, Inc. | Peritoneal dialysis transfer set with antimicrobial properties |
US11534595B2 (en) | 2018-11-07 | 2022-12-27 | Icu Medical, Inc. | Device for delivering an antimicrobial composition into an infusion device |
US11541221B2 (en) | 2018-11-07 | 2023-01-03 | Icu Medical, Inc. | Tubing set with antimicrobial properties |
US11541220B2 (en) | 2018-11-07 | 2023-01-03 | Icu Medical, Inc. | Needleless connector with antimicrobial properties |
WO2020106985A1 (en) | 2018-11-21 | 2020-05-28 | Pursuit Vascular, Inc. | Antimicrobial device comprising a cap with ring and insert |
JP2024500319A (ja) | 2020-12-07 | 2024-01-09 | アイシーユー・メディカル・インコーポレーテッド | 腹膜透析キャップ、システム、及び方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH451186A (de) * | 1961-11-02 | 1968-05-15 | Santen Phamarceutical Co Ltd | Verfahren zur Herstellung von N-Mercaptopropionylglycin und dessen Derivaten |
CA1009252A (en) * | 1972-10-03 | 1977-04-26 | Santen Pharmaceutical Co. | N-(mercaptoacyl) aminoacids |
US3857951A (en) * | 1973-09-14 | 1974-12-31 | Cassenne Lab Sa | Use of 2-mercaptopropionylglycine and its alkali metal salts in treating respiratory diseases |
AU509899B2 (en) | 1976-02-13 | 1980-05-29 | E.R. Squibb & Sons, Inc. | Proline derivatives and related compounds |
-
1976
- 1976-05-10 US US05/684,606 patent/US4053651A/en not_active Expired - Lifetime
-
1977
- 1977-03-03 US US05/773,865 patent/US4112119A/en not_active Expired - Lifetime
- 1977-04-07 AU AU24106/77A patent/AU513622B2/en not_active Expired
- 1977-04-13 CA CA000276034A patent/CA1119177A/en not_active Expired
- 1977-04-13 ZA ZA00772256A patent/ZA772256B/xx unknown
- 1977-04-14 IE IE783/77A patent/IE44821B1/en not_active IP Right Cessation
- 1977-04-14 GB GB15559/77A patent/GB1577415A/en not_active Expired
- 1977-04-20 DE DE19772717548 patent/DE2717548A1/de active Granted
- 1977-04-21 CS CS772657A patent/CS204001B2/cs unknown
- 1977-04-29 NL NL7704712A patent/NL7704712A/xx not_active Application Discontinuation
- 1977-05-03 DD DD7700198728A patent/DD130477A5/xx unknown
- 1977-05-04 FR FR7713595A patent/FR2372624A1/fr active Granted
- 1977-05-07 PL PL1977197963A patent/PL107991B1/pl unknown
- 1977-05-07 PL PL1977205447A patent/PL106032B1/pl unknown
- 1977-05-09 NO NO771623A patent/NO771623L/no unknown
- 1977-05-09 YU YU01168/77A patent/YU116877A/xx unknown
- 1977-05-09 HU HU77SU947A patent/HU177750B/hu unknown
- 1977-05-09 SE SE7705382A patent/SE7705382L/xx not_active Application Discontinuation
- 1977-05-09 DK DK203177A patent/DK203177A/da unknown
- 1977-05-09 CH CH576677A patent/CH620202A5/fr not_active IP Right Cessation
- 1977-05-10 JP JP5420177A patent/JPS52136117A/ja active Granted
- 1977-05-10 BE BE177439A patent/BE854458A/xx not_active IP Right Cessation
- 1977-05-10 SU SU772478851A patent/SU818479A3/ru active
-
1978
- 1978-01-18 FR FR7801417A patent/FR2367741A1/fr active Granted
- 1978-07-05 SU SU782632596A patent/SU955857A3/ru active
- 1978-07-05 SU SU782632600A patent/SU697049A3/ru active
-
1980
- 1980-05-22 CH CH402580A patent/CH621763A5/fr not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2572830C2 (ru) * | 2010-03-17 | 2016-01-20 | Акцо Нобель Кемикалз Интернэшнл Б.В. | Способ деполимеризации полисульфидов и получения простых бисмеркаптодиэфиров |
Also Published As
Publication number | Publication date |
---|---|
GB1577415A (en) | 1980-10-22 |
SU818479A3 (ru) | 1981-03-30 |
SE7705382L (sv) | 1977-11-11 |
PL197963A1 (pl) | 1978-03-28 |
FR2372624A1 (fr) | 1978-06-30 |
CH620202A5 (ru) | 1980-11-14 |
YU116877A (en) | 1982-08-31 |
AU2410677A (en) | 1978-10-12 |
ZA772256B (en) | 1978-03-29 |
SU955857A3 (ru) | 1982-08-30 |
FR2367741B1 (ru) | 1982-10-29 |
US4053651A (en) | 1977-10-11 |
PL107991B1 (pl) | 1980-03-31 |
DE2717548C2 (ru) | 1990-05-03 |
JPS6120544B2 (ru) | 1986-05-22 |
CH621763A5 (ru) | 1981-02-27 |
IE44821B1 (en) | 1982-04-07 |
DD130477A5 (de) | 1978-04-05 |
CA1119177A (en) | 1982-03-02 |
DE2717548A1 (de) | 1977-12-01 |
US4112119A (en) | 1978-09-05 |
AU513622B2 (en) | 1980-12-11 |
IE44821L (en) | 1977-11-10 |
DK203177A (da) | 1977-11-11 |
BE854458A (fr) | 1977-11-10 |
PL106032B1 (pl) | 1979-11-30 |
FR2367741A1 (fr) | 1978-05-12 |
HU177750B (en) | 1981-12-28 |
CS204001B2 (en) | 1981-03-31 |
FR2372624B1 (ru) | 1980-05-09 |
JPS52136117A (en) | 1977-11-14 |
NL7704712A (nl) | 1977-11-14 |
NO771623L (no) | 1977-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU697049A3 (ru) | Способ получени меркаптоациламинокислот или их солей | |
RU2038350C1 (ru) | Способ получения производных мутилина или их солей с кислотами | |
SU888821A3 (ru) | Способ получени 5-(замещенный фенил)-оксазолидинонов или их серусодержащих аналогов | |
McManus et al. | Tetrazole Analogs of Amino Acids1 | |
JPS6059226B2 (ja) | プロリン誘導体および関連化合物 | |
DK159680B (da) | Cycliske imider til anvendelse ved fremstilling af cycliske aminosyrer | |
SU526292A3 (ru) | Способ получени производных 8-азапурин-6-она | |
Bhargava et al. | Studies on the Structure of the Skin Protein-bound Compounds Following Topical Application of 1, 2, 5, 6-Dibenzanthracene-9, 10-C14. II. Nature of the 2-Phenylphenanthrene-3, 2'-dicarboxylic Acid-Protein Bond1, 2 | |
SU837319A3 (ru) | Способ получени оптических изомеров -(2-бЕНзгидРилэТил)- -(1-фЕНилэТил)-АМиНА или иХ СОлЕй | |
IL116384A (en) | Iliden assemblies and their preparation | |
SE431643B (sv) | Terapeutiskt aktiva halogensubstituerade prolinderivat innehallande svavel och forfarande for deras tillverkning | |
SU584774A3 (ru) | Способ получени производных изоксазола | |
SU489310A3 (ru) | Способ получени производного бифенилацетамида или его соли | |
JPH01500522A (ja) | 2,3‐ジアミノアクリロニトリル誘導体 | |
US4170654A (en) | Antihypertensive compositions containing N-heterocyclicalanines and α- | |
SU604497A3 (ru) | Способ получени тетрамизола или его солей | |
Gunda et al. | 2-Amino-1-phenyl-propan-1, 3-diol as chiral auxiliary. Application in the synthesis of cis 3-Phthalimido-4-styryl-2-azetidinones | |
US2540946A (en) | Pyridoxal-histamine and processes for preparing the same | |
KR910006125B1 (ko) | 아세메타신의 제조방법 | |
GB2036723A (en) | Mercaptoacylpiperazine carboxylic acid compounds | |
SU503517A3 (ru) | Способ получени производных индолилуксусной кислоты или их солей | |
HU194164B (en) | Process for production of 1,2-dihydroxi-3-//2-indolil-1,1-dialkyl-ethil/-amin/-prophanes | |
JPS61129159A (ja) | 保護化アミノ酸アミド化合物の精製法 | |
SU328572A1 (ru) | СПОСОБ ПОЛУЧЕНИЯ АМИДОВ ИЛИ ПЕПТИДОВ N-АЦИЛ-а-АМИНОКИСЛОТЫ | |
US4173581A (en) | Process for the preparation of alkylthiosemicarbazides |